logo
episode-header-image
Jul 2023
9m 10s

Pure Science : Does aspartame cause canc...

THEPRINT
About this episode

In a new report, the WHO has categorised the artificial sweetener aspartame as “possibly cancerous” to humans. But the groupings used by the IARC, which decides these categories, don’t mean the same things we think they do. ThePrint #PureScience, Sandhya Ramesh explains. 

Up next
Yesterday
CutTheClutter: Indo-US nuclear deal:Buried anti-Americanism, ended India's nuclear apartheid & why it still matters
Twenty years ago, a week from now, India signed a nuclear deal with the US that redefined its foreign policy, and caused a split in the Indian political sphere. The deal was a landmark moment in terms of access to technology, but also raised uncomfortable questions about liabilit ... Show More
20m 54s
Yesterday
ThePrintAM:WHAT HAS NSA DOVAL SAID ON OP SINDOOR?
WHAT HAS NSA DOVAL SAID ON OP SINDOOR? ----more---- https://theprint.in/defence/show-me-one-photo-of-any-damage-in-india-nsa-ajit-doval-dares-foreign-media-on-op-sindoor/2686905/ 
4m 12s
Yesterday
ThePrintPod: How Argentina has taken a hyper-West stand on defence , but is pragmatic on economic ties with China
Argentina President Javier Milei has often been hailed by US President Donald Trump as a “great new hope” in Latin America. The country under Milei has taken a sharply pro-Western stance. His outspoken criticism of China has been welcomed by many in the West, particularly in Wash ... Show More
12m 35s
Recommended Episodes
Aug 2023
Does Aspartame Give You Cancer?
For decades, health-minded consumers have sought alternatives to natural sugar -- aspartame, marketed under any number of brand names, is one of the most popular artificial sweeteners in the world. Yet it appears this billion-dollar industry may have a dark side: for many years, ... Show More
1h 4m
Aug 2023
Ep. #1108: Alan Aragon on Aspartame and Cancer
Have you seen the headlines? Social media and the internet at large are abuzz with the controversy surrounding the well-known artificial sweetener aspartame.  The recent classification of aspartame as a possible human carcinogen (category 2B) by the International Agency for Resea ... Show More
59m 30s
Mar 2024
The Evolution Of Cancer Treatment
Recently, the US Food and Drug Administration approved a first-of-its-kind cancer therapy to treat aggresive forms of skin cancer. It has us thinking of the long history of cancer. One of the first recorded mentions of cancer appears in an ancient Egyptian text from around 3000 B ... Show More
13m 58s
Feb 2024
Why we need to rethink how we talk about cancer
For over a century, cancer has been classified by areas of the body - lung cancer, breast cancer, skin cancer etc. And yet modern medical research is telling us that the molecular and genetic mechanisms behind cancers are not necessarily tied to parts of the body. Many drugs deve ... Show More
14m 53s
Jul 2023
Aspartame: The Surprisingly Interesting Science and History
Greg and Lyndsey dive into the history, conspiracies, science, and media coverage of aspartame to present a thorough overview of the recent WHO reports linking aspartame and cancer risk. Is this one of the longest "podcast episodes" ever? Probably. But it's packed with fascinatin ... Show More
5h 43m
Apr 2023
Sweet Science
Researchers from London’s Francis Crick Institute have found a type of artificial sweetener is able to dampen down immune system responses - at least in mice. Karen Vousden and Fabio Zani tell us about the implications. And Ronan McCarthy from Brunel University has found a range ... Show More
40m 41s
Sep 2023
Glyphosate : un « cancérogène probable » bientôt réautorisé ?
Mercredi 20 septembre, la Commission européenne a proposé de renouveler pour dix ans l’autorisation d’utilisation du glyphosate dans l’Union européenne. Cet herbicide « miracle », commercialisé depuis les années 1970 par Monsanto – entre-temps racheté par Bayer –, et qui permet d ... Show More
12m 2s
Jan 2020
PaccMann^RL: Designing Anticancer Drugs with Reinforcement Learning w/ Jannis Born - #341
Today we’re joined by Jannis Born, Ph.D. student at ETH & IBM Research Zurich, to discuss his “PaccMann^RL” research. Jannis details how his background in computational neuroscience applies to this research, how RL fits into the goal of anticancer drug discovery, the effect DL ha ... Show More
42m 4s